Apex Biotechnology (TPE:1733) Operating Cash Flow per Share : NT$3.15 (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Operating Cash Flow per Share?

Apex Biotechnology's operating cash flow per share for the three months ended in Mar. 2024 was NT$0.45. Apex Biotechnology's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$3.15.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Apex Biotechnology was 1483.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -2.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -5.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Apex Biotechnology's Operating Cash Flow per Share or its related term are showing as below:

TPE:1733' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -59.9 Med: -3.05 Max: 55.8
Current: -2.6

During the past 13 years, Apex Biotechnology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 55.80% per year. The lowest was -59.90% per year. And the median was -3.05% per year.

TPE:1733's 3-Year OCF Growth Rate is ranked worse than
57.83% of 1233 companies
in the Biotechnology industry
Industry Median: 3.3 vs TPE:1733: -2.60

Apex Biotechnology Operating Cash Flow per Share Historical Data

The historical data trend for Apex Biotechnology's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Operating Cash Flow per Share Chart

Apex Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

4.09

2.48

1.70

0.26

2.30

Apex Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.39	1.33	0.30	1.08	0.45

Competitive Comparison of Apex Biotechnology's Operating Cash Flow per Share

For the Biotechnology subindustry, Apex Biotechnology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apex Biotechnology's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's Price-to-Operating-Cash-Flow falls into.

Apex Biotechnology Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Apex Biotechnology's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	230.391	/	100.326
	=	2.30

Apex Biotechnology's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	45.58	/	100.295
	=	0.45

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.15

Apex Biotechnology Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology (TPE:1733) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines